HTG Molecular Diagnostics (HTGM) Stock Forecast, Price Target & Predictions
HTGM Stock Forecast
HTG Molecular Diagnostics stock forecast is as follows: an average price target of $0.17 (represents a -65.28% downside from HTGM’s last price of $0.48) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
HTGM Price Target
HTGM Analyst Ratings
HTG Molecular Diagnostics Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 15, 2022 | - | H.C. Wainwright | $0.17 | $0.09 | 92.31% | -65.28% |
HTG Molecular Diagnostics Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $0.48 | $0.48 | $0.48 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Dec 29, 2022 | H.C. Wainwright | Buy | Buy | Hold |
HTGM Forecast FAQ
Is HTG Molecular Diagnostics a good buy?
Yes, according to 1 Wall Street analysts, HTG Molecular Diagnostics (HTGM) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of HTGM's total ratings.
What is HTGM's price target?
HTG Molecular Diagnostics (HTGM) average price target is $0.167 with a range of $0.167 to $0.167, implying a -65.28% from its last price of $0.48. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will HTG Molecular Diagnostics stock go up soon?
According to Wall Street analysts' prediction for HTGM stock, the company can go down by -65.28% (from the last price of $0.48 to the average price target of $0.167), down by -65.28% based on the highest stock price target, and down by -65.28% based on the lowest stock price target.
Can HTG Molecular Diagnostics stock reach $1?
HTGM's average twelve months analyst stock price target of $0.167 does not support the claim that HTG Molecular Diagnostics can reach $1 in the near future.